Bio

Dong Hur is a Stanford Medical Student applying into General Surgery, with a keen interest in using big data analysis and machine learning to address healthcare disparities. His research focuses on trauma center access and the use of circulating tumor DNA for the early detection of soft tissue sarcoma. Outside of medicine, Dong Hur enjoys hiking, playing pickleball, and camping

Membership Organizations

  • SIG: Surgery Interest Group, Coleader
  • Arbor Free Clinic, Volunteer
  • Pacific Free Clinic, Volunteer

Education & Certifications

  • Bachelor of Arts, Harvard University (2020)
  • BA, Harvard University, Major: Neuroscience | Minor: Computer Science (2020)

Contact

  • Academic
    dhur@stanford.edu
    University - Student Department: School of Medicine Position: Graduate, Medicine

Additional Info

Links

Current Clinical Interests

  • General Surgery

All Publications

  • Circulating Tumor DNA in the Monitoring of Soft Tissue Sarcoma Treatment and Recurrence. Annals of surgical oncology Sun, B. J., Li, A. Y., Hur, D. G., Zhou, M., Poultsides, G. A., Delitto, D. J., Lee, B. 2024

    View details for DOI 10.1245/s10434-024-15902-9

    View details for PubMedID 39060690

    View details for PubMedCentralID 10119774

  • The burden of readmissions after rib fractures among older adults. Surgery Choi, J., Hur, D. G., Tennakoon, L., Spain, D. A., Staudenmayer, K. 2024

    Abstract

    The index hospitalization morbidity and mortality of rib fractures among older adults (aged ≥65 years) is well-known, yet the burden and risks for readmissions after rib fractures in this vulnerable population remain understudied. We aimed to characterize the burdens and etiologies associated with 3-month readmissions among older adults who suffer rib fractures. We hypothesized that readmissions would be common and associated with modifiable etiologies.This survey-weighted retrospective study using the 2017 and 2019 National Readmissions Database evaluated adults aged ≥65 years hospitalized with multiple rib fractures and without major extrathoracic injuries. The main outcome was the proportion of patients experiencing all-cause 3-month readmissions. We assessed the 5 leading principal readmission diagnoses overall and delineated them by index hospitalization discharge disposition (home or facility). Sensitivity analysis using clinical classification categories characterized readmissions that could reasonably represent rib fracture-related sequelae.In 2017, 25,092 patients met the inclusion criteria, with 20% (N = 4,894) experiencing 3-month readmissions. Six percent of patients did not survive their readmission. The 5 leading principal readmission diagnoses were sepsis (many associated with secondary diagnoses of pneumonia [41%] or urinary tract infections [41%]), hypertensive heart/kidney disease, hemothorax, pneumonia, and respiratory failure. In 2019, a comparable 3-month readmission rate of 23% and identical 5 leading diagnoses were found. Principal readmission diagnosis of hemothorax was associated with the shortest time to readmission (median [interquartile range]:9 [5-23] days). Among patients discharged home after index hospitalization, pleural effusion-possibly representing mischaracterized hemothorax-was among the leading principal readmission diagnoses. Some patients readmitted with a principal diagnosis of hemothorax or pleural effusion had these diagnoses at index hospitalization; a lower proportion of these patients underwent pleural fluid intervention during index hospitalization compared with readmission. On sensitivity analysis, 30% of 3-month readmissions were associated with principal diagnoses suggesting rib fracture-related sequelae.Readmissions are not infrequent among older adults who suffer rib fractures, even in the absence of major extrathoracic injuries. Future studies should better characterize how specific complications associated with readmissions, such as pneumonia, urinary tract infections, and delayed hemothoraces, could be mitigated.

    View details for DOI 10.1016/j.surg.2024.05.021

    View details for PubMedID 38880698

  • Pediatric Trauma Center Access, Regional Injury Burden, and Socioeconomic Disadvantage. JAMA surgery Hur, D. G., Ren, A. L., Yue, T. M., Spain, D. A., Choi, J. 2024

    View details for DOI 10.1001/jamasurg.2024.0962

    View details for PubMedID 38748438

  • Access to Burn Care in the US. JAMA surgery Hur, D. G., Yao, J., Yue, T. M., Sheckter, C. C., Choi, J. 2024

    Abstract

    This cross-sectional study examines burn incidence rates and accessibility of American Burn Association-verified or self-designated burn centers from 2013 to 2019.

    View details for DOI 10.1001/jamasurg.2023.7763

    View details for PubMedID 38353985

  • Detection of Circulating Tumor DNA Predicts Recurrence in Soft Tissue Sarcomas Sun, B. J., Li, A., Alobuia, W., Hur, D., Daniel, S. K., Kirane, A. R., Poultsides, G., Lee, B. SPRINGER. 2023: S16

    View details for Web of Science ID 001046841200028

  • Predictive Value of Clinical Complete Response after Chemoradiation for Rectal Cancer Liu, C., Boncompagni, A. A., Perrone, K., Agarwal, A., Hur, D. G., Lopez, I., Sheth, V., Morris, A. M. LIPPINCOTT WILLIAMS & WILKINS. 2022: S51-S52

    View details for DOI 10.1097/01.XCS.0000893308.54894.46

    View details for Web of Science ID 000867889300080

https://orcid.org/0000-0001-5410-8189